id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2019-0006-0005,DEA,DEA-2019-0006,Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV,Rule,,2020-01-07T05:00:00Z,2020,1,2020-01-07T05:00:00Z,,2020-01-22T15:01:40Z,2019-27955,0,0,0900006484275aec
DEA-2019-0006-0007,DEA,DEA-2019-0006,Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV,Rule,,2019-11-08T05:00:00Z,2019,11,2019-11-08T05:00:00Z,,2020-01-22T15:19:31Z,C1-2019-12723,0,0,090000648413057a
DEA-2019-0006-0006,DEA,DEA-2019-0006,Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV,Rule,,2019-11-08T05:00:00Z,2019,11,2019-11-08T05:00:00Z,,2020-01-22T15:18:18Z,C1-2019-12,0,0,0900006484130575
DEA-2019-0006-0002,DEA,DEA-2019-0006,Solriamfetol DEA 8 Factor,Supporting & Related Material,,2019-06-17T04:00:00Z,2019,6,,,2019-06-18T11:59:52Z,,0,0,0900006483d17f5d
DEA-2019-0006-0001,DEA,DEA-2019-0006,Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV,Rule,,2019-06-17T04:00:00Z,2019,6,2019-06-17T04:00:00Z,2019-07-18T03:59:59Z,2019-07-17T01:03:20Z,2019-12723,0,0,0900006483d16d91
DEA-2019-0006-0003,DEA,DEA-2019-0006,HHS Letter for Solriamfetol,Supporting & Related Material,,2019-06-17T04:00:00Z,2019,6,,,2019-06-17T15:16:24Z,,0,0,0900006483d17f16